NDC 17478-080

CAPASTAT SULFATE

Capreomycin

CAPASTAT SULFATE is a Intramuscular; Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Akorn. The primary component is Capreomycin Sulfate.

Product ID17478-080_186fb088-ece1-4ba8-a120-9e8b8d4c0057
NDC17478-080
Product TypeHuman Prescription Drug
Proprietary NameCAPASTAT SULFATE
Generic NameCapreomycin
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2009-08-01
Marketing CategoryNDA / NDA
Application NumberNDA050095
Labeler NameAkorn
Substance NameCAPREOMYCIN SULFATE
Active Ingredient Strength1 g/1
Pharm ClassesAntimycobacterial [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 17478-080-50

1 INJECTION, POWDER, FOR SOLUTION in 1 CARTON (17478-080-50)
Marketing Start Date2009-08-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17478-080-50 [17478008050]

CAPASTAT SULFATE INJECTION, POWDER, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA050095
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-08-01

Drug Details

Active Ingredients

IngredientStrength
CAPREOMYCIN SULFATE1 g/1

OpenFDA Data

SPL SET ID:808e4421-2b9c-41e1-a82c-39256b112ae8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 201860
  • 239208
  • UPC Code
  • 0317478080503
  • Pharmacological Class

    • Antimycobacterial [EPC]

    NDC Crossover Matching brand name "CAPASTAT SULFATE" or generic name "Capreomycin"

    NDCBrand NameGeneric Name
    17478-080CAPASTAT SULFATECapreomycin
    42658-004CAPREOMYCIN SULFATECapreomycin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.